 Erin Baschal
Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Haplotypes | 9 | 2020 | 494 | 1.450 |
Why?
| | Scoliosis | 6 | 2021 | 215 | 1.370 |
Why?
| | Major Histocompatibility Complex | 5 | 2012 | 227 | 1.060 |
Why?
| | Diabetes Mellitus, Type 1 | 17 | 2025 | 3715 | 0.910 |
Why?
| | HLA-DQ Antigens | 5 | 2018 | 181 | 0.770 |
Why?
| | Polymorphism, Single Nucleotide | 10 | 2020 | 2189 | 0.760 |
Why?
| | Microtubules | 2 | 2018 | 279 | 0.700 |
Why?
| | HLA-DR Antigens | 5 | 2022 | 228 | 0.620 |
Why?
| | Extracellular Matrix | 3 | 2021 | 528 | 0.560 |
Why?
| | Actin Cytoskeleton | 1 | 2018 | 103 | 0.560 |
Why?
| | Polymorphism, Genetic | 4 | 2021 | 660 | 0.550 |
Why?
| | HLA-B Antigens | 3 | 2011 | 62 | 0.510 |
Why?
| | Genetic Predisposition to Disease | 10 | 2025 | 2426 | 0.490 |
Why?
| | Exome | 3 | 2018 | 231 | 0.480 |
Why?
| | Alleles | 6 | 2022 | 891 | 0.480 |
Why?
| | Heparan Sulfate Proteoglycans | 1 | 2014 | 26 | 0.460 |
Why?
| | Genome, Human | 3 | 2012 | 425 | 0.440 |
Why?
| | HLA-DR3 Antigen | 2 | 2010 | 80 | 0.380 |
Why?
| | Genotyping Techniques | 1 | 2012 | 75 | 0.370 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 2 | 2009 | 46 | 0.370 |
Why?
| | Genotype | 8 | 2011 | 1916 | 0.320 |
Why?
| | Pedigree | 5 | 2021 | 514 | 0.300 |
Why?
| | Otitis Media | 2 | 2021 | 165 | 0.290 |
Why?
| | HLA Antigens | 2 | 2025 | 240 | 0.290 |
Why?
| | Mutation, Missense | 2 | 2020 | 341 | 0.280 |
Why?
| | HLA-DP Antigens | 1 | 2007 | 33 | 0.270 |
Why?
| | Thiabendazole | 1 | 2006 | 1 | 0.260 |
Why?
| | Genes, cdc | 1 | 2006 | 11 | 0.260 |
Why?
| | HLA-DQ beta-Chains | 3 | 2020 | 63 | 0.250 |
Why?
| | Carbamates | 1 | 2006 | 50 | 0.250 |
Why?
| | Addison Disease | 3 | 2011 | 43 | 0.250 |
Why?
| | Cytoplasm | 1 | 2006 | 274 | 0.240 |
Why?
| | Schizosaccharomyces pombe Proteins | 1 | 2006 | 78 | 0.240 |
Why?
| | Benzimidazoles | 1 | 2006 | 170 | 0.240 |
Why?
| | Schizosaccharomyces | 1 | 2006 | 92 | 0.230 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2006 | 455 | 0.210 |
Why?
| | Cell Cycle Proteins | 1 | 2006 | 617 | 0.190 |
Why?
| | Multifactorial Inheritance | 2 | 2021 | 174 | 0.190 |
Why?
| | Gene Frequency | 4 | 2011 | 521 | 0.190 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 14 | 0.180 |
Why?
| | Islets of Langerhans | 2 | 2023 | 803 | 0.180 |
Why?
| | Linkage Disequilibrium | 3 | 2011 | 268 | 0.180 |
Why?
| | Plasminogen | 1 | 2020 | 30 | 0.170 |
Why?
| | Steroid 21-Hydroxylase | 2 | 2011 | 30 | 0.170 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2022 | 190 | 0.170 |
Why?
| | Insulin | 2 | 2008 | 2409 | 0.170 |
Why?
| | Cytoskeleton | 1 | 2021 | 191 | 0.160 |
Why?
| | Genetic Variation | 2 | 2015 | 991 | 0.160 |
Why?
| | Autoantibodies | 5 | 2025 | 1496 | 0.160 |
Why?
| | Zebrafish | 2 | 2021 | 499 | 0.150 |
Why?
| | Humans | 28 | 2025 | 137585 | 0.150 |
Why?
| | Methyldopa | 1 | 2018 | 7 | 0.150 |
Why?
| | HLA-D Antigens | 2 | 2008 | 34 | 0.140 |
Why?
| | Cation Transport Proteins | 1 | 2018 | 134 | 0.140 |
Why?
| | Antigen Presentation | 1 | 2018 | 218 | 0.130 |
Why?
| | Antibody Formation | 1 | 2018 | 298 | 0.130 |
Why?
| | Influenza, Human | 1 | 2022 | 622 | 0.130 |
Why?
| | Immunity, Cellular | 1 | 2018 | 268 | 0.130 |
Why?
| | Melanoma | 1 | 2022 | 760 | 0.120 |
Why?
| | Sequence Analysis | 1 | 2014 | 36 | 0.120 |
Why?
| | Genetic Association Studies | 2 | 2018 | 377 | 0.110 |
Why?
| | Membrane Proteins | 1 | 2021 | 1164 | 0.110 |
Why?
| | Child | 8 | 2025 | 21935 | 0.110 |
Why?
| | T-Lymphocytes | 2 | 2023 | 1996 | 0.110 |
Why?
| | Male | 12 | 2025 | 67762 | 0.100 |
Why?
| | Autoimmunity | 2 | 2010 | 908 | 0.100 |
Why?
| | Algorithms | 2 | 2012 | 1704 | 0.100 |
Why?
| | HapMap Project | 1 | 2012 | 5 | 0.100 |
Why?
| | Chromosomes, Human | 1 | 2012 | 44 | 0.090 |
Why?
| | Homozygote | 2 | 2009 | 203 | 0.090 |
Why?
| | Ubiquitins | 1 | 2011 | 36 | 0.090 |
Why?
| | Female | 12 | 2025 | 73304 | 0.090 |
Why?
| | Telomere | 2 | 2011 | 280 | 0.090 |
Why?
| | Chromosome Mapping | 2 | 2009 | 523 | 0.090 |
Why?
| | Recombination, Genetic | 1 | 2012 | 204 | 0.090 |
Why?
| | Endocrine Cells | 1 | 2010 | 7 | 0.090 |
Why?
| | Genetic Loci | 1 | 2011 | 288 | 0.080 |
Why?
| | DNA Replication | 1 | 2011 | 238 | 0.080 |
Why?
| | HLA-A Antigens | 1 | 2009 | 55 | 0.080 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2023 | 718 | 0.070 |
Why?
| | Sequence Analysis, DNA | 1 | 2011 | 812 | 0.070 |
Why?
| | Conserved Sequence | 1 | 2009 | 239 | 0.070 |
Why?
| | Minisatellite Repeats | 1 | 2008 | 42 | 0.070 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2009 | 203 | 0.070 |
Why?
| | Heterozygote | 1 | 2009 | 293 | 0.070 |
Why?
| | Infant | 5 | 2025 | 9465 | 0.070 |
Why?
| | Base Sequence | 1 | 2011 | 2181 | 0.070 |
Why?
| | Survival | 1 | 2007 | 38 | 0.070 |
Why?
| | Nuclear Family | 1 | 2007 | 54 | 0.070 |
Why?
| | Histocompatibility Antigens | 1 | 2008 | 105 | 0.070 |
Why?
| | Histocompatibility Testing | 1 | 2007 | 126 | 0.070 |
Why?
| | Phleomycins | 1 | 2006 | 1 | 0.070 |
Why?
| | HLA-DP beta-Chains | 1 | 2007 | 86 | 0.070 |
Why?
| | Drug Resistance, Fungal | 1 | 2006 | 7 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2011 | 2900 | 0.070 |
Why?
| | Transformation, Genetic | 1 | 2006 | 16 | 0.070 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2006 | 16 | 0.060 |
Why?
| | Software | 1 | 2012 | 665 | 0.060 |
Why?
| | Child, Preschool | 5 | 2025 | 11074 | 0.060 |
Why?
| | Chromosome Segregation | 1 | 2006 | 47 | 0.060 |
Why?
| | DNA, Fungal | 1 | 2006 | 80 | 0.060 |
Why?
| | Epistasis, Genetic | 1 | 2006 | 70 | 0.060 |
Why?
| | Logistic Models | 1 | 2011 | 2074 | 0.060 |
Why?
| | Phenotype | 1 | 2014 | 3196 | 0.060 |
Why?
| | Spindle Apparatus | 1 | 2006 | 102 | 0.060 |
Why?
| | Morphogenesis | 1 | 2006 | 166 | 0.060 |
Why?
| | Cell Polarity | 1 | 2006 | 141 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1774 | 0.050 |
Why?
| | Actins | 1 | 2006 | 416 | 0.050 |
Why?
| | Protein Processing, Post-Translational | 1 | 2006 | 465 | 0.050 |
Why?
| | DNA Damage | 1 | 2006 | 420 | 0.050 |
Why?
| | Cohort Studies | 2 | 2015 | 5742 | 0.050 |
Why?
| | Age of Onset | 1 | 2025 | 518 | 0.050 |
Why?
| | Microbiota | 2 | 2021 | 762 | 0.050 |
Why?
| | Risk Factors | 4 | 2009 | 10388 | 0.050 |
Why?
| | Diabetic Ketoacidosis | 1 | 2025 | 201 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2006 | 493 | 0.050 |
Why?
| | Mice, Inbred NOD | 2 | 2018 | 601 | 0.050 |
Why?
| | Animals | 6 | 2021 | 36940 | 0.050 |
Why?
| | Phosphorylation | 1 | 2006 | 1759 | 0.050 |
Why?
| | Adult | 5 | 2018 | 37929 | 0.050 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 336 | 0.040 |
Why?
| | Mice | 4 | 2021 | 17787 | 0.040 |
Why?
| | Ear, Middle | 1 | 2020 | 85 | 0.040 |
Why?
| | Mutation | 2 | 2021 | 3958 | 0.040 |
Why?
| | Cilia | 1 | 2021 | 178 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2021 | 380 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2021 | 549 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 242 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2022 | 539 | 0.040 |
Why?
| | Ions | 1 | 2018 | 70 | 0.040 |
Why?
| | Adolescent | 4 | 2025 | 21513 | 0.040 |
Why?
| | Zebrafish Proteins | 1 | 2021 | 288 | 0.040 |
Why?
| | Peptides | 1 | 2023 | 985 | 0.030 |
Why?
| | Risk Assessment | 1 | 2007 | 3457 | 0.030 |
Why?
| | Young Adult | 3 | 2025 | 13209 | 0.030 |
Why?
| | Movement | 1 | 2018 | 278 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 730 | 0.030 |
Why?
| | Bone and Bones | 1 | 2018 | 317 | 0.030 |
Why?
| | Kyphosis | 1 | 2015 | 39 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 795 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 971 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2022 | 3556 | 0.030 |
Why?
| | Collagen | 1 | 2015 | 452 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2018 | 2167 | 0.020 |
Why?
| | HLA-B15 Antigen | 1 | 2011 | 13 | 0.020 |
Why?
| | HLA-B8 Antigen | 1 | 2010 | 14 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 5757 | 0.020 |
Why?
| | Graves Disease | 1 | 2009 | 34 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2010 | 399 | 0.020 |
Why?
| | HLA-DRB1 Chains | 1 | 2009 | 112 | 0.020 |
Why?
| | Microsatellite Repeats | 1 | 2009 | 168 | 0.020 |
Why?
| | Interferon-alpha | 1 | 2009 | 198 | 0.020 |
Why?
| | Risk | 1 | 2010 | 912 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2009 | 6079 | 0.020 |
Why?
| | Metabolic Networks and Pathways | 1 | 2008 | 180 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2009 | 1062 | 0.020 |
Why?
| | Autoimmune Diseases | 1 | 2010 | 460 | 0.020 |
Why?
| | Middle Aged | 2 | 2022 | 33479 | 0.020 |
Why?
| | Disease Progression | 1 | 2009 | 2757 | 0.010 |
Why?
| | Chronic Disease | 1 | 2008 | 1793 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2009 | 5472 | 0.010 |
Why?
| | Aged | 1 | 2009 | 23961 | 0.010 |
Why?
|
|
Baschal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|